Cosmetics Europe and eight other European brand and manufacturer groups said online marketplaces, social media and ...

AI “dis-intermediates all of the things that we've tried to do to help patients make proper choices, not only with regular ...

Thirteen companies received US FDA warning letters between April and September 2026, including BlephEx, Koven Technologies ...

The FDA is encouraging lupus drug sponsors to consider enrolling pediatric patients in or alongside their pivotal trials to ...

CMS Medicare Director David Brooks acknowledged concerns about the impact that Medicare negotiated prices for Part B drugs ...

The negative PFS result for the cancer vaccine drew disappointment, but the Phase II/III AHEAD-MERIT trial’s statistical plan ...

International weakness and an Abiomed slump weigh on the segment, while executives promise a better fourth quarter.

Foghorn Therapeutics’s market cap fell below its cash following Eli Lilly’s exit and Sanofi hit a multi-year low after ...

Eli Lilly’s oral GLP-1 contender orforglipron is among four new drugs up for marketing approval recommendations by the ...

A further settlement of over $1m has been secured to compensate victims of an alleged US generic pricing inflation scheme ...

This year’s resurgence in IPOs continues, but there are signs that investor enthusiasm for biotech has cooled in recent weeks ...

The newly appointed members of the European Medicines Agency’s New Approach Methodologies Operational Expert Group are drawn ...